Your session is about to expire
← Back to Search
Diagnostic Test
Pelvic Binder Radiography for Pelvic Fracture
N/A
Waitlist Available
Led By Joseph T Patterson, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at diagnostic intervention, immediately following baseline data collection.
Awards & highlights
Study Summary
This trial tests a new way to measure the movement of pelvic injuries, to help determine how stable they are.
Who is the study for?
This trial is for adults over 18 who've been admitted to the Los Angeles County + USC Medical Center within 3 weeks of a specific type of pelvic injury (LC1) from blunt or blast trauma. They must speak English or Spanish and be able to follow up; those with severe psychiatric issues, intellectual challenges without support, living outside the area, prisoners, homeless, or with certain other injuries are excluded.Check my eligibility
What is being tested?
The study tests a new method using stress radiography on patients with LC1 pelvic ring injuries. It aims to measure how much the pelvis moves under pressure to determine stability after an injury. Participants will undergo this novel imaging technique as part of their standard care.See study design
What are the potential side effects?
Since this trial involves diagnostic imaging rather than medication or surgery, side effects may include discomfort during the application of compressive stress and potential temporary aggravation of pain in the pelvic region due to movement during testing.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at diagnostic intervention, immediately following baseline data
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at diagnostic intervention, immediately following baseline data
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pelvic fracture displacement at 10 kg of stress
Pelvic fracture displacement at 5 kg of stress
Trial Design
1Treatment groups
Experimental Treatment
Group I: Diagnostic InterventionExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,596,228 Total Patients Enrolled
Joseph T Patterson, MDPrincipal InvestigatorKeck School of Medicine of the University of Southern California
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My injury was caused by a blunt force or an explosion.I have a severe pelvic injury.I have a severe pelvic injury that caused internal bleeding and low blood pressure.I have a severe pelvic injury that needs stabilization.I do not have a severe pelvic injury that is getting worse.My pelvic injury is being tested under stress conditions.I have not needed advanced procedures to stabilize my blood pressure.I have an injury in my pelvic area that prevents safe use of a pelvic compression device.I am older than 18 years.My pelvic injury is stable and not life-threatening.I was recently admitted to the emergency department or transferred to Los Angeles County + USC Medical Center.I have a specific type of pelvic fracture.I can communicate in English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Diagnostic Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the uppermost limit of participants in this experiment?
"Affirmative. Patient recruitment is ongoing for this research project; the initial posting was made on February 1st, 2023 with a recent update occurring on May 22nd of that same year. The study requires 50 individuals from one medical facility to participate."
Answered by AI
Is the testing of this treatment still available to participants?
"This trial, initially advertised on February 1st 2023, is currently enrolling new patients as indicated by clinicaltrials.gov's most recent update from May 22nd 2023."
Answered by AI
Share this study with friends
Copy Link
Messenger